J Med Microbiol Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Farrell, D J
Right arrow Articles by Reinert, R R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Farrell, D J
Right arrow Articles by Reinert, R R
Agricola
Right arrow Articles by Farrell, D J
Right arrow Articles by Reinert, R R
J Med Microbiol 53 (2004), 1109-1117; DOI: 10.1099/jmm.0.45647-0
© 2004 Society for General Microbiology
ISSN 0022-2615

Global distribution of Streptococcus pneumoniae serotypes isolated from paediatric patients during 1999–2000 and the in vitro efficacy of telithromycin and comparators

D J Farrell1, S G Jenkins2 and R R Reinert3

1Medical and Molecular Microbiology, GR Micro Limited, 7–9 William Road, London NW1 3ER, UK 2Carolinas Medical Center, Charlotte, NC, USA 3Institute of Medical Microbiology, National Reference Center for Streptococci, Aachen, Germany

Correspondence D. J. Farrell D.Farrell{at}grmicro.co.uk

Received February 20, 2004
Accepted July 6, 2004

Few data exist on the distribution of Streptococcus pneumoniae serotypes in many countries and in non-invasive disease overall. Here, data are presented from 772 paediatric isolates from children with community-acquired respiratory tract infections isolated from the PROTEKT global surveillance study during 1999–2000. Overall, 60.0 % of isolates were covered by the 7-valent pneumococcal vaccine formulation (PCV7), with greater coverage in the USA compared with Europe (69.6 vs 55.5 %, P = 0.014). Geographically dispersed clones of serogroups 3, 11 and 15 accounted for most of the isolates outside PCV7 coverage. Overall, macrolide, penicillin and cotrimoxazole non-susceptibility rates were high; however, all isolates were susceptible to telithromycin. Although only 7.4 % of isolates were resistant to amoxycillin/clavulanate, a higher prevalence of resistance was found in isolates from the USA and South Korea. This study shows the feasibility and importance of serotyping antibiotic surveillance study isolates and the potential of telithromycin as an important option for empiric therapy.

Abbreviations: IPD, invasive pneumococcal disease; MLSB, macrolide–lincosamide–streptogramin B; MLST, multilocus sequence typing; PROTEKT, Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin; RTI, respiratory tract infection; SG, serogroup; ST, serotype.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
C. Draing, M. Pfitzenmaier, S. Zummo, G. Mancuso, A. Geyer, T. Hartung, and S. von Aulock
Comparison of Lipoteichoic Acid from Different Serotypes of Streptococcus pneumoniae
J. Biol. Chem., November 10, 2006; 281(45): 33849 - 33859.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
D. J. Farrell and D. Felmingham
The PROTEKT global study (year 4) demonstrates a continued lack of resistance development to telithromycin in Streptococcus pneumoniae
J. Antimicrob. Chemother., October 1, 2005; 56(4): 795 - 797.
[Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
D. M. O'Halloran and M. T. Cafferkey
Multiplex PCR for Identification of Seven Streptococcus pneumoniae Serotypes Targeted by a 7-Valent Conjugate Vaccine
J. Clin. Microbiol., July 1, 2005; 43(7): 3487 - 3490.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
K. Kosowska, D. B. Hoellman, G. Lin, C. Clark, K. Credito, P. McGhee, B. Dewasse, B. Bozdogan, S. Shapiro, and P. C. Appelbaum
Antipneumococcal Activity of Ceftobiprole, a Novel Broad-Spectrum Cephalosporin
Antimicrob. Agents Chemother., May 1, 2005; 49(5): 1932 - 1942.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS
Copyright © 2004 Society for General Microbiology.